162 related articles for article (PubMed ID: 35653194)
1. Immune landscape of a genetically engineered murine model of glioma compared with human glioma.
Zamler DB; Shingu T; Kahn LM; Huntoon K; Kassab C; Ott M; Tomczak K; Liu J; Li Y; Lai I; Zorilla-Veloz R; Yee C; Rai K; Kim BY; Watowich SS; Heimberger AB; Draetta GF; Hu J
JCI Insight; 2022 Jun; 7(12):. PubMed ID: 35653194
[TBL] [Abstract][Full Text] [Related]
2. Increasing glioma-associated monocytes leads to increased intratumoral and systemic myeloid-derived suppressor cells in a murine model.
Chae M; Peterson TE; Balgeman A; Chen S; Zhang L; Renner DN; Johnson AJ; Parney IF
Neuro Oncol; 2015 Jul; 17(7):978-91. PubMed ID: 25537019
[TBL] [Abstract][Full Text] [Related]
3. Single-cell RNA sequencing reveals immunosuppressive myeloid cell diversity during malignant progression in a murine model of glioma.
Rajendran S; Hu Y; Canella A; Peterson C; Gross A; Cam M; Nazzaro M; Haffey A; Serin-Harmanci A; Distefano R; Nigita G; Wang W; Kreatsoulas D; Li Z; Sepeda JA; Sas A; Hester ME; Miller KE; Elemento O; Roberts RD; Holland EC; Rao G; Mardis ER; Rajappa P
Cell Rep; 2023 Mar; 42(3):112197. PubMed ID: 36871221
[TBL] [Abstract][Full Text] [Related]
4. Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progression.
Yeo AT; Rawal S; Delcuze B; Christofides A; Atayde A; Strauss L; Balaj L; Rogers VA; Uhlmann EJ; Varma H; Carter BS; Boussiotis VA; Charest A
Nat Immunol; 2022 Jun; 23(6):971-984. PubMed ID: 35624211
[TBL] [Abstract][Full Text] [Related]
5. Diverse Macrophages Constituted the Glioma Microenvironment and Influenced by PTEN Status.
Zhou F; Shi Q; Fan X; Yu R; Wu Z; Wang B; Tian W; Yu T; Pan M; You Y; Wang Y
Front Immunol; 2022; 13():841404. PubMed ID: 35265085
[TBL] [Abstract][Full Text] [Related]
6. Leveraging the replication-competent avian-like sarcoma virus/tumor virus receptor-A system for modeling human gliomas.
Kanvinde PP; Malla AP; Connolly NP; Szulzewsky F; Anastasiadis P; Ames HM; Kim AJ; Winkles JA; Holland EC; Woodworth GF
Glia; 2021 Sep; 69(9):2059-2076. PubMed ID: 33638562
[TBL] [Abstract][Full Text] [Related]
7. Glioma-associated microglia/macrophages display an expression profile different from M1 and M2 polarization and highly express Gpnmb and Spp1.
Szulzewsky F; Pelz A; Feng X; Synowitz M; Markovic D; Langmann T; Holtman IR; Wang X; Eggen BJ; Boddeke HW; Hambardzumyan D; Wolf SA; Kettenmann H
PLoS One; 2015; 10(2):e0116644. PubMed ID: 25658639
[TBL] [Abstract][Full Text] [Related]
8. SYK inhibition blocks proliferation and migration of glioma cells and modifies the tumor microenvironment.
Moncayo G; Grzmil M; Smirnova T; Zmarz P; Huber RM; Hynx D; Kohler H; Wang Y; Hotz HR; Hynes NE; Keller G; Frank S; Merlo A; Hemmings BA
Neuro Oncol; 2018 Apr; 20(5):621-631. PubMed ID: 29401256
[TBL] [Abstract][Full Text] [Related]
9. Role of myeloid cells in the immunosuppressive microenvironment in gliomas.
Locarno CV; Simonelli M; Carenza C; Capucetti A; Stanzani E; Lorenzi E; Persico P; Della Bella S; Passoni L; Mavilio D; Bonecchi R; Locati M; Savino B
Immunobiology; 2020 Jan; 225(1):151853. PubMed ID: 31703822
[TBL] [Abstract][Full Text] [Related]
10. Immune microenvironment of experimental rat C6 gliomas resembles human glioblastomas.
Gieryng A; Pszczolkowska D; Bocian K; Dabrowski M; Rajan WD; Kloss M; Mieczkowski J; Kaminska B
Sci Rep; 2017 Dec; 7(1):17556. PubMed ID: 29242629
[TBL] [Abstract][Full Text] [Related]
11. Immune suppression in gliomas.
Grabowski MM; Sankey EW; Ryan KJ; Chongsathidkiet P; Lorrey SJ; Wilkinson DS; Fecci PE
J Neurooncol; 2021 Jan; 151(1):3-12. PubMed ID: 32542437
[TBL] [Abstract][Full Text] [Related]
12. The Role of Myeloid Cells in GBM Immunosuppression.
Lin YJ; Wu CY; Wu JY; Lim M
Front Immunol; 2022; 13():887781. PubMed ID: 35711434
[TBL] [Abstract][Full Text] [Related]
13. F11R is a novel monocyte prognostic biomarker for malignant glioma.
Pong WW; Walker J; Wylie T; Magrini V; Luo J; Emnett RJ; Choi J; Cooper ML; Griffith M; Griffith OL; Rubin JB; Fuller GN; Piwnica-Worms D; Feng X; Hambardzumyan D; DiPersio JF; Mardis ER; Gutmann DH
PLoS One; 2013; 8(10):e77571. PubMed ID: 24147027
[TBL] [Abstract][Full Text] [Related]
14. Novel murine glioblastoma models that reflect the immunotherapy resistance profile of a human disease.
Chen CH; Chin RL; Hartley GP; Lea ST; Engel BJ; Hsieh CE; Prasad R; Roszik J; Shingu T; Lizee GA; Heimberger AB; Millward SW; Hu J; Hong DS; Curran MA
Neuro Oncol; 2023 Aug; 25(8):1415-1427. PubMed ID: 36705543
[TBL] [Abstract][Full Text] [Related]
15. CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas.
Flores-Toro JA; Luo D; Gopinath A; Sarkisian MR; Campbell JJ; Charo IF; Singh R; Schall TJ; Datta M; Jain RK; Mitchell DA; Harrison JK
Proc Natl Acad Sci U S A; 2020 Jan; 117(2):1129-1138. PubMed ID: 31879345
[TBL] [Abstract][Full Text] [Related]
16. Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment.
Müller S; Kohanbash G; Liu SJ; Alvarado B; Carrera D; Bhaduri A; Watchmaker PB; Yagnik G; Di Lullo E; Malatesta M; Amankulor NM; Kriegstein AR; Lim DA; Aghi M; Okada H; Diaz A
Genome Biol; 2017 Dec; 18(1):234. PubMed ID: 29262845
[TBL] [Abstract][Full Text] [Related]
17. Specialized functions and sexual dimorphism explain the functional diversity of the myeloid populations during glioma progression.
Ochocka N; Segit P; Wojnicki K; Cyranowski S; Swatler J; Jacek K; Grajkowska W; Kaminska B
Cell Rep; 2023 Jan; 42(1):111971. PubMed ID: 36640350
[TBL] [Abstract][Full Text] [Related]
18. Myeloid Cells in Glioblastoma Microenvironment.
De Leo A; Ugolini A; Veglia F
Cells; 2020 Dec; 10(1):. PubMed ID: 33374253
[TBL] [Abstract][Full Text] [Related]
19. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
[TBL] [Abstract][Full Text] [Related]
20. The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy.
Qian J; Wang C; Wang B; Yang J; Wang Y; Luo F; Xu J; Zhao C; Liu R; Chu Y
J Neuroinflammation; 2018 Oct; 15(1):290. PubMed ID: 30333036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
